These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34817175)

  • 1. Development of a Dual Fluorescent and Magnetic Resonance False Neurotransmitter That Reports Accumulation and Release from Dopaminergic Synaptic Vesicles.
    Post MR; Lee WL; Guo J; Sames D; Sulzer D
    ACS Chem Neurosci; 2021 Dec; 12(24):4546-4553. PubMed ID: 34817175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine release at individual presynaptic terminals visualized with FFNs.
    Zhang H; Gubernator NG; Yue M; Staal RG; Mosharov EV; Pereira D; Balsanek V; Vadola PA; Mukherjee B; Edwards RH; Sulzer D; Sames D
    J Vis Exp; 2009 Aug; (30):. PubMed ID: 19721412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent false neurotransmitters visualize dopamine release from individual presynaptic terminals.
    Gubernator NG; Zhang H; Staal RG; Mosharov EV; Pereira DB; Yue M; Balsanek V; Vadola PA; Mukherjee B; Edwards RH; Sulzer D; Sames D
    Science; 2009 Jun; 324(5933):1441-4. PubMed ID: 19423778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Stem Cell-Derived Platform for Studying Single Synaptic Vesicles in Dopaminergic Synapses.
    Gu H; Lazarenko RM; Koktysh D; Iacovitti L; Zhang Q
    Stem Cells Transl Med; 2015 Aug; 4(8):887-93. PubMed ID: 26025981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain.
    Rodriguez PC; Pereira DB; Borgkvist A; Wong MY; Barnard C; Sonders MS; Zhang H; Sames D; Sulzer D
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):870-5. PubMed ID: 23277566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APP+, a fluorescent analogue of the neurotoxin MPP+, is a marker of catecholamine neurons in brain tissue, but not a fluorescent false neurotransmitter.
    Karpowicz RJ; Dunn M; Sulzer D; Sames D
    ACS Chem Neurosci; 2013 May; 4(5):858-69. PubMed ID: 23647019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroactive fluorescent false neurotransmitter FFN102 partially replaces dopamine in PC12 cell vesicles.
    Hu L; Savy A; Grimaud L; Guille-Collignon M; Lemaître F; Amatore C; Delacotte J
    Biophys Chem; 2019 Feb; 245():1-5. PubMed ID: 30500608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualizing neurotransmitter secretion at individual synapses.
    Sames D; Dunn M; Karpowicz RJ; Sulzer D
    ACS Chem Neurosci; 2013 May; 4(5):648-51. PubMed ID: 23862751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIRFM and pH-sensitive GFP-probes to evaluate neurotransmitter vesicle dynamics in SH-SY5Y neuroblastoma cells: cell imaging and data analysis.
    Daniele F; Di Cairano ES; Moretti S; Piccoli G; Perego C
    J Vis Exp; 2015 Jan; (95):. PubMed ID: 25741799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic optical imaging platforms: Examining pharmacological modulation of neurotransmitter release at discrete synapses.
    Merchant P; Sulzer D; Sames D
    Neuropharmacology; 2015 Nov; 98():90-4. PubMed ID: 25837712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemical tools for imaging dopamine release.
    Post MR; Sulzer D
    Cell Chem Biol; 2021 Jun; 28(6):748-764. PubMed ID: 33894160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic vesicle fusion is modulated through feedback inhibition by dopamine auto-receptors.
    Formisano R; Mersha MD; Caplan J; Singh A; Rankin CH; Tavernarakis N; Dhillon HS
    Synapse; 2020 Jan; 74(1):e22131. PubMed ID: 31494966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
    Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
    J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic vesicle pools and dynamics.
    Alabi AA; Tsien RW
    Cold Spring Harb Perspect Biol; 2012 Aug; 4(8):a013680. PubMed ID: 22745285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualizing synaptic dopamine efflux with a 2D composite nanofilm.
    Bulumulla C; Krasley AT; Cristofori-Armstrong B; Valinsky WC; Walpita D; Ackerman D; Clapham DE; Beyene AG
    Elife; 2022 Jul; 11():. PubMed ID: 35786443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural and morphometric investigations on the mechanism of neurotransmitter release from synaptic vesicles.
    Dymecki J; Walski M; Medyńska E
    Acta Neuropathol Suppl; 1981; 7():381-5. PubMed ID: 6111889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic vesicle pool-specific modification of neurotransmitter release by intravesicular free radical generation.
    Afuwape OA; Wasser CR; Schikorski T; Kavalali ET
    J Physiol; 2017 Feb; 595(4):1223-1238. PubMed ID: 27723113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular underpinnings of synaptic vesicle pool heterogeneity.
    Crawford DC; Kavalali ET
    Traffic; 2015 Apr; 16(4):338-64. PubMed ID: 25620674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
    Teng L; Crooks PA; Dwoskin LP
    J Neurochem; 1998 Jul; 71(1):258-65. PubMed ID: 9648873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis.
    Nemani VM; Lu W; Berge V; Nakamura K; Onoa B; Lee MK; Chaudhry FA; Nicoll RA; Edwards RH
    Neuron; 2010 Jan; 65(1):66-79. PubMed ID: 20152114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.